https://prabadinews.com/
  • October 7, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Biosimilar Mvasi Demonstrates Similar Ophthalmic Safety Profile to Reference Product Avastin

Biosimilar Mvasi Demonstrates Similar Ophthalmic Safety Profile to Reference Product Avastin

A recent study reveals Mvasi’s comparable safety profile to Avastin for retinal diseases, highlighting the need for on-label biosimilars in ophthalmology.

administrator

Related Articles